Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease (2023)
- Authors:
- Autor USP: OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM
- Unidade: FM
- DOI: 10.52787/agl.v53i3.329
- Subjects: NEOPLASIAS GÁSTRICAS; CARCINOMA HEPATOCELULAR; MODELOS ANIMAIS; PREVENÇÃO DE DOENÇAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: ACTA GASTROENTEROLOGICA LATINOAMERICANA
- ISSN: 0300-9033
- Volume/Número/Paginação/Ano: v. 53, n. 3, p. 265-282, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FERRARI, J. Tonin et al. Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease. ACTA GASTROENTEROLOGICA LATINOAMERICANA, v. 53, n. 3, p. 265-282, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58621. Acesso em: 13 fev. 2026. -
APA
Ferrari, J. T., Guerreiro, G. T. S., Longo, L., Silveira, T. R. D., Cerski, C. T. S., Tozawa, E., et al. (2023). Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease. ACTA GASTROENTEROLOGICA LATINOAMERICANA, 53( 3), 265-282. doi:10.52787/agl.v53i3.329 -
NLM
Ferrari JT, Guerreiro GTS, Longo L, Silveira TRD, Cerski CTS, Tozawa E, Oliveira CPMS de, Alvares-da-Silva MR, Uribe-Cruz C. Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease [Internet]. ACTA GASTROENTEROLOGICA LATINOAMERICANA. 2023 ; 53( 3): 265-282.[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58621 -
Vancouver
Ferrari JT, Guerreiro GTS, Longo L, Silveira TRD, Cerski CTS, Tozawa E, Oliveira CPMS de, Alvares-da-Silva MR, Uribe-Cruz C. Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease [Internet]. ACTA GASTROENTEROLOGICA LATINOAMERICANA. 2023 ; 53( 3): 265-282.[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58621 - Efeito do s-nitroso-n-acetilcisteína (Snac) na fibrogênese hepática em modelo experimental de doença hepática gordurosa não alcoólica (DHGNA)
- Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
- Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease
- Cryptogenic chronic hepatitis: looking for an ideal diagnostic algorithm
- Ultrasound elastography in patients with fatty liver disease
- Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis
- Síndrome metabólica após o transplante hepático
- Non-pharmacological management options for MAFLD: a practical guide
- Risk of Liver Cancer in MASLD: role of Genetic Risk Scores
- PNPLA3 GENE POLYMORPHISM AND RED MEAT CONSUMPTION INCREASED FIBROSIS RISK IN NASH BIOPSY-PROVEN PATIENTS UNDER MEDICAL FOLLOW-UP IN A TERTIARY CENTER IN SOUTHWEST BRAZIL
Informações sobre o DOI: 10.52787/agl.v53i3.329 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
